Echinocandins have been on the market for 20 years, yet they are the newest class of 25 antifungal drugs. The human fungal pathogen Cryptococcus neoformans is intrinsically resistant 26 to the echinocandin antifungal drug caspofungin, which targets the b-1,3-glucan synthase 27 encoded by the FKS1. Analysis of a C. neoformans puf4∆ mutant, lacking the pumilio/FBF RNA 28 binding protein family member Puf4, revealed exacerbated caspofungin resistance. In contrast, 29 overexpression of PUF4 resulted in caspofungin sensitivity. The FKS1 mRNA contains three 30 Puf4-binding elements (PBEs) in its 5' untranslated region. Puf4 binds with specificity to this 31 region of the FKS1. The FKS1 mRNA was destabilized in the puf4∆ mutant, and the abundance 32 of the FKS1 mRNA was reduced compared to wild type, suggesting that Puf4 is a positive 33 regulator FKS1 mRNA stability. In addition to FKS1, the abundance of additional cell wall 34 biosynthesis genes, including chitin synthases (CHS3, CHS4, CHS6) and deacetylases (CDA1, 35 CDA2, CDA3) as well as a b-1,6-glucan synthase gene (SKN1) was regulated by Puf4 during a 36 caspofungin time course. The use of fluorescent dyes to quantify cell wall components revealed 37 that the puf4∆ mutant had increased chitin content, suggesting a cell wall composition that is 38 less reliant on b-1,3-glucan. Overall, our findings suggest a mechanism by which caspofungin 39 resistance, and more broadly, cell wall biogenesis, is regulated post-transcriptionally by Puf4. 40 41 Importance 42 Cryptococcus neoformans is an environmental fungus that causes pulmonary and central 43 nervous system infections. It is also responsible for 15% of AIDS-related deaths. A major 44 contributor to the high morbidity and mortality statistics is the lack of safe and effective 45 antifungal therapies, especially in resource-poor settings. Yet, antifungal drug development has 46 stalled in the pharmaceutical industry. Therefore, it is of importance to understand the mechanism by which C. neoformans is resistant to caspofungin in order to design adjunctive 48 therapies to potentiate its activity toward this important pathogen.
3 Puf4-FLAG cell lysate (Fig 2B, arrow) . Because, we detected an interaction between Puf4 and 152 the 5'UTR sequence of FKS1, we went on to investigate if loss of Puf4 would alter the 153 abundance or stability of FKS1 mRNA. FKS1 mRNA abundance in mid-log grown cultures of 154 puf4∆ cells were decreased 20% compared to wild type grown in parallel (Fig. 2C) . PUF 155 proteins are known mRNA stability regulators, and so we asked if the reduction in FKS1 mRNA 156 in the puf4D mutant was due to destabilization. We performed an mRNA stability time-course
The FKS1 mRNA abundance is upregulated in wild type cells at 45 minutes post-caspofungin basal levels at later time points (Fig. 4A ). These different trends in transcript abundance 180 following caspofungin treatment may suggest that the cell wall b-1,3-glucan levels may differ 181 between wild type and the puf4∆ cells.
183
To investigate the functional consequences of the trends we observed at the transcript 184 level, we utilized aniline blue staining to investigate the b-1,3-glucan levels in the cell wall of the 185 wild type and the puf4∆ cells. Aniline blue specifically binds to b-1,3-glucan (29). Following 186 growth to mid-log phase, both strains were treated with caspofungin for 60 minutes and stained 187 with aniline blue. Fluorescence microscopy revealed that aniline blue staining mainly localized 188 to the cell wall in the mid-logarithmic stage cells. In addition to the cell wall staining pattern, 189 staining pattern of the caspofungin treated cells also contained an intracellular punctate pattern 190 ( Fig. 4B ). Quantification of the microscopy images showed that the puf4∆ cells had 30% less b-191 1,3-glucan compared to the wild type cells both at the mid-logarithmic stage and following 192 treatment with caspofungin ( Fig. 4C ). We concluded that the post-transcriptional regulation of 193 the FKS1 mRNA by Puf4 directly affects cellular b-1,3-glucan levels.
195
Deletion of PUF4 leads to dysregulation of cell wall biosynthesis genes.
196
A recent study revealed that multiple cell wall genes are influenced by caspofungin treatment 197 (19) . We assessed the same panel of mRNAs for the presence of a putative Puf4 binding 198 element, and found that several caspofungin-sensitive genes contain Puf4 binding elements 9 202
We next asked if the caspofungin-responsiveness of these genes was dependent on 203 Puf4. Following growth to the mid-log stage, we challenged both wild type and the puf4∆ cells 204 with 16 µg/ml caspofungin over a 60-minute time course and investigated the changes in the 205 transcript abundance of genes involved in cell wall biosynthesis. We found that CHS3 (Chitin
206
Synthase 3) is downregulated following caspofungin treatment in the puf4∆ cells compared to 207 wild type ( Fig 5A) . Conversely, CHS4 and CHS6 are found to be upregulated in the puf4∆ 208 mutant compared to wild type ( Fig 5B and 5C ). Elevated cell wall chitin content is shown to 209 reduce susceptibility to caspofungin in Candida species (18). Therefore, upregulation of chitin 210 synthase genes in the puf4∆ mutant may also contribute to the resistance phenotype in
211
Cryptococcus. The synthesis of chitosan from chitin is catalyzed by the chitin deacetylases and 212 chitosan is necessary for the integrity of the cell wall (30). During the caspofungin time course, 213 we found out that CDA1 (chitin deacetylase 1) is upregulated in the puf4∆ mutant. On the 214 contrary, CDA2 and CDA3 were found to be downregulated in the puf4∆ mutant ( Fig 5D-F) . The
215
CDA3 is the only chitin deacetylase gene that contain a PBE (Table 1) . Of note, Cda1 is the 216 major chitin deacetylase and the only chitin deacetylase that is necessary for virulence (31).
218
Lastly, we looked at the regulation of a-glucan and b-glucan genes during the 219 caspofungin time-course. We have found that AGS1 (a-glucan synthase 1) was present at a 220 slightly higher abundance in the puf4∆ compared to the wild type at the basal levels. Which then 221 decreased significantly at the 30 minutes time point. The AGS1 contains a PBE at its 5'UTR, 222 and may be a Puf4 target (Table 1) . The b-1,6-glucan synthase genes KRE6 and SKN1 showed 223 opposite trends. Both wild type and the puf4∆ cells had comparable levels of KRE6 at t=0 224 minutes, yet the puf4∆ cells had a significantly decreasing trend of KRE6 abundance during the puf4∆ compared to wild type and remained upregulated throughout the 60 minutes ( Fig 5G-I) .
227
The PBE element that is present in the SKN1 3' UTR compared to KRE6, which does not have 228 a PBE, may explain the opposite trends in post-transcriptional gene regulation.
230
Our quantitative analysis of the mRNAs involved in cell wall biosynthesis showed that
231
Puf4 plays a regulatory role in the fate of these mRNAs and modulate their abundances during 232 caspofungin treatment.
234
Puf4 stabilizes cell wall biosynthesis genes involved in chitin and α-glucan synthesis.
235
To gain more mechanistic insight on how Puf4 may control the cell wall biosynthesis related 236 transcript abundances, we investigated the mRNA stability of the same transcripts. mRNA 237 stability is a crucial step in transcriptome remodeling to adapt to various environmental and 238 compound stressors (32). Therefore, we hypothesized that Puf4 may modulate cell wall 239 biosynthesis genes post-transcriptionally at the mRNA stability level.
241
We found that CHS3 and CHS4 were destabilized to a great degree in the puf4∆ mutant, 242 whereas CDA3, AGS1 and CDA1 exhibited a slight reduction in stability in the absence of Puf4.
243
Unlike other genes we investigated, CDA1 does not contain a PBE and was included as a 244 negative control. Even though we expected CDA1 stability to be like wild type, it too was slightly 245 destabilized ( Fig. 6 ). Our results show that Puf4-mediated post-transcriptional gene regulation in 246 mRNA stability may be crucial for cell wall remodeling that contributes to the caspofungin 247 resistance.
Since we have shown that Puf4 regulates cell wall biosynthesis related transcript abundances 252 and their mRNA stability, we further investigated the functional consequences of this Puf4 loss 253 by assessing cell wall chitin and chitooligomer content using calcofluor and wheat germ 254 agglutinin staining, respectively. Microscopy ( Fig 7A) and flow cytometry analysis ( Fig 7B-C) of 255 the chitin content using calcofluor dye showed that the cell wall chitin content increases 256 following caspofungin treatment in both wild type and the puf4∆ cells. Importantly, the puf4∆ 257 cells had significantly more chitin following caspofungin treatment compared to that of wild type 258 cells. In other pathogenic fungi such as Candida species and Aspergillus fumigatus, increased 259 chitin content is protective against caspofungin (17, 18) .
261
Microbial cultures show molecular and phenotypical heterogeneity that may be important 262 within the scope of antimicrobial resistance (33). Histogram graphs of the calcofluor staining 263 showed that the increase in chitin content is at a sub-population level ( Fig 7B) . While the majority 264 of the puf4∆ cell population shifted to a high chitin phenotype, wild type cells showed a more 265 heterogeneous population. Lastly, we looked at the exposed chitooligomers as another form of 266 chitin-derived structure, and saw a modest increase compared in the puf4∆ cells compared to the 267 wild type.
269
In this study, we have demonstrated that the caspofungin resistance of C. neoformans is 270 regulated at the post-transcriptional level through the direct interaction of the mRNA encoding its 271 target, FKS1, as well as through the regulation of multiple genes that regulate cell wall 272 composition. Post-transcriptional regulation of cell wall remodeling genes by Puf4 has functional 273 consequences, as the absence of Puf4 results to massive remodeling of the C. neoformans cell 274 wall components. Future work will investigate the effect of Puf4 on the translation of these target
Discussion

278
The search for novel antifungal therapies is an ongoing battle in medical mycology, especially 279 with the growing number of fungal outbreaks and emerging drug resistance issues (33, 34) . The 280 latest class of antifungals approved by the FDA are the echinocandins, and Cryptococcus is 281 intrinsically resistant to this class of antifungals (9, 14, 15, 36) . Even though it is crucial to 282 design new therapies, it is also imperative to understand the resistance mechanisms to the 283 existing antifungals to avoid similar scenarios and to design adjunctive therapies to remedy the 284 current resistance issues. In this study, we elucidated the role of post-transcriptional gene 285 regulation in the molecular mechanism of action behind the caspofungin resistance. We 
311
Cell wall maintenance and perturbations in response to drug induced stress have a 312 broad appreciation by the medical mycology (42). For example, the mar1∆ mutant exhibits a 313 defect in intracellular trafficking of cell wall synthases and therefore exhibits a cell wall 314 composition that contains elevated exposed chitin and decreased glucan levels. These changes 315 in the cell wall composition and exposure of different carbohydrates play meaningful roles in the 316 immune recognition by the host and activate various signaling events in the host system (43).
317
Another example is the enhanced recognition of the ccr4∆ mutant by alveolar macrophages due 318 to increased unmasking of the b-1,3-glucan (44). The importance of Ccr4, an mRNA 319 deadenylase, in glucan masking is further evidence that post-transcriptional processes are 320 essential for adaptation to a number of stressors, including caspofungin treatment. In this study,
321
we show that Puf4 is a major regulator of cell wall biogenesis. We report that cell wall 322 biosynthesis genes showed different trends of expression in the puf4∆ compared to wild type in 323 caspofungin time-course experiments. We have also shown that FKS1, CHS3 and CHS4 324 mRNAs were destabilized in the absence of Puf4. This regulation of certain cell wall biogenesis 
Materials and Methods
virulent strain gifted from Peter Williamson (UIC, NIAID), which is derived from H99O gifted by water once and then OD600 was equaled to 0.3 in YPD broth. 50 µl of YPD broth containing the 407 2x the final caspofungin concentration was placed in each well then 50 µl of the OD600 adjusted 408 cultures were placed in each well. Plate was incubated at 30˚C for 20 hours while shaking in a 409 double orbital fashion and OD600 was measured every 10 minutes during this kinetic assay.
411
Electrophoretic mobility shift assay (EMSA).
412
EMSA reactions were set and analyzed as described previously (27). Briefly, all RNA binding 413 reactions contained 5 µg of total protein lysate, 0.5 pmol of the TYE705-labeled 414 oligonucleotide (IDT), and 4 µl 5x EMSA buffer (75 mM HEPES pH 7.4, 200 mM KCl, 25 415 mM MgCl2, 25% glycerol, 5 mM dithiothreitol (DTT), and 0.5 mg/ml yeast tRNA) in a total 416 volume of 20 µl. For competition reactions, 5x, 10x, and 20x more unlabeled wild type or 417 mutant oligonucleotides added in addition to the TYE705-labeled oligonucleotide. Reaction 418 mixtures were incubated at room temperature for 20 minutes, and run on DNA retardation 419 gel, then electrophoresed at 100V. Gels were imaged using a LiCor Odyssey imaging 420 system. 421
Overnight cultures grown at 30˚C were used to inoculate 35 mL of YPD broth at the OD600 log stage cultures were supplemented with 250 µg/mL of the transcriptional inhibitor tubes and pelleted every 15 minutes for 60 minutes. 50 µl RLT supplemented with 1% b-437 mercaptoethanol was added to each pellet prior to flash freezing in liquid nitrogen. Pellets were 438 stored at -80 ˚C until RNA extraction. Cells were lysed by bead beating using glass beads. RNA 
513
Data analysis was performed using the GraphPad Prism software version 6. Each figure legend 514 contains the statistical test information that is used to assess the statistical significance. Briefly,
515
we have utilized the one-phase exponential decay analysis to determine the half-life of the 516 mRNAs analyzed. Immunoblot data was analyzed using unpaired t-test with Welch's correction.
517
Gene expression and microscopy quantification data were analyzed using either one-way or 
